428 related articles for article (PubMed ID: 22365075)
1. The use of recombinant luteinizing hormone in patients undergoing assisted reproductive techniques with advanced reproductive age: a systematic review and meta-analysis.
Hill MJ; Levens ED; Levy G; Ryan ME; Csokmay JM; DeCherney AH; Whitcomb BW
Fertil Steril; 2012 May; 97(5):1108-14.e1. PubMed ID: 22365075
[TBL] [Abstract][Full Text] [Related]
2. Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged ≥35 years: a randomized controlled trial.
Vuong TN; Phung HT; Ho MT
Hum Reprod; 2015 May; 30(5):1188-95. PubMed ID: 25740882
[TBL] [Abstract][Full Text] [Related]
3. Recombinant luteinizing hormone supplementation in assisted reproductive technology: a systematic review.
Alviggi C; Conforti A; Esteves SC; Andersen CY; Bosch E; Bühler K; Ferraretti AP; De Placido G; Mollo A; Fischer R; Humaidan P;
Fertil Steril; 2018 Apr; 109(4):644-664. PubMed ID: 29653717
[TBL] [Abstract][Full Text] [Related]
4. Addition of neither recombinant nor urinary luteinizing hormone was associated with an improvement in the outcome of autologous in vitro fertilization/intracytoplasmatic sperm injection cycles under regular clinical settings: a multicenter observational analysis.
Schwarze JE; Crosby JA; Zegers-Hochschild F
Fertil Steril; 2016 Dec; 106(7):1714-1717.e1. PubMed ID: 27678033
[TBL] [Abstract][Full Text] [Related]
5. The evaluation of recombinant LH supplementation in patients with suboptimal response to recombinant FSH undergoing IVF treatment with GnRH agonist down-regulation.
Yazıcı Yılmaz F; Görkemli H; Çolakoğlu MC; Aktan M; Gezginç K
Gynecol Endocrinol; 2015 Feb; 31(2):141-4. PubMed ID: 25237892
[TBL] [Abstract][Full Text] [Related]
6. Highly purified hMG versus recombinant FSH plus recombinant LH in intrauterine insemination cycles in women ≥35 years: a RCT.
Moro F; Scarinci E; Palla C; Romani F; Familiari A; Tropea A; Leoncini E; Lanzone A; Apa R
Hum Reprod; 2015 Jan; 30(1):179-85. PubMed ID: 25398971
[TBL] [Abstract][Full Text] [Related]
7. Clinical effects of ovulation induction with recombinant follicle-stimulating hormone supplemented with recombinant luteinizing hormone or low-dose recombinant human chorionic gonadotropin in the midfollicular phase in microdose cycles in poor responders.
Berkkanoglu M; Isikoglu M; Aydin D; Ozgur K
Fertil Steril; 2007 Sep; 88(3):665-9. PubMed ID: 17292895
[TBL] [Abstract][Full Text] [Related]
8. Comparison of stimulation with clomiphene citrate in combination with recombinant follicle-stimulating hormone and recombinant luteinizing hormone to stimulation with a gonadotropin-releasing hormone agonist protocol: a prospective, randomized study.
Weigert M; Krischker U; Pöhl M; Poschalko G; Kindermann C; Feichtinger W
Fertil Steril; 2002 Jul; 78(1):34-9. PubMed ID: 12095487
[TBL] [Abstract][Full Text] [Related]
9. Exogenous luteinizing hormone in controlled ovarian hyperstimulation for assisted reproduction techniques.
Ferraretti AP; Gianaroli L; Magli MC; D'angelo A; Farfalli V; Montanaro N
Fertil Steril; 2004 Dec; 82(6):1521-6. PubMed ID: 15589853
[TBL] [Abstract][Full Text] [Related]
10. A comparison of outcomes from in vitro fertilization cycles stimulated with either recombinant luteinizing hormone (LH) or human chorionic gonadotropin acting as an LH analogue delivered as human menopausal gonadotropins, in subjects with good or poor ovarian reserve: a retrospective analysis.
Dahan MH; Agdi M; Shehata F; Son W; Tan SL
Eur J Obstet Gynecol Reprod Biol; 2014 Jan; 172():70-3. PubMed ID: 24314801
[TBL] [Abstract][Full Text] [Related]
11. Ovarian response and pregnancy outcome in poor-responder women: a randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles.
Barrenetxea G; Agirregoikoa JA; Jiménez MR; de Larruzea AL; Ganzabal T; Carbonero K
Fertil Steril; 2008 Mar; 89(3):546-53. PubMed ID: 17531989
[TBL] [Abstract][Full Text] [Related]
12. The ratio of exogenous Luteinizing hormone to Follicle stimulating hormone administered for controlled ovarian stimulation is associated with oocytes' number and competence.
Albu D; Albu A
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31850491
[TBL] [Abstract][Full Text] [Related]
13. Recombinant LH supplementation in women of 35 years and older undergoing IVF?
König TE; van der Houwen LE; Lambalk CB
Fertil Steril; 2012 Jul; 98(1):e10-1; author reply e12. PubMed ID: 22633649
[No Abstract] [Full Text] [Related]
14. Recombinant luteinizing hormone supplementation to recombinant follicle-stimulating hormone induced ovarian hyperstimulation in the GnRH-antagonist multiple-dose protocol.
Griesinger G; Schultze-Mosgau A; Dafopoulos K; Schroeder A; Schroer A; von Otte S; Hornung D; Diedrich K; Felberbaum R
Hum Reprod; 2005 May; 20(5):1200-6. PubMed ID: 15665010
[TBL] [Abstract][Full Text] [Related]
15. Impaired outcome of controlled ovarian hyperstimulation in women with thyroid autoimmune disease.
Magri F; Capelli V; Gaiti M; Brambilla E; Montesion L; Rotondi M; Spinillo A; Nappi RE; Chiovato L
Thyroid; 2013 Oct; 23(10):1312-8. PubMed ID: 23556516
[TBL] [Abstract][Full Text] [Related]
16. The role of recombinant LH in women with hypo-response to controlled ovarian stimulation: a systematic review and meta-analysis.
Conforti A; Esteves SC; Di Rella F; Strina I; De Rosa P; Fiorenza A; Zullo F; De Placido G; Alviggi C
Reprod Biol Endocrinol; 2019 Feb; 17(1):18. PubMed ID: 30728019
[TBL] [Abstract][Full Text] [Related]
17. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
[TBL] [Abstract][Full Text] [Related]
18. Recombinant human luteinizing hormone co-treatment in ovarian stimulation for assisted reproductive technology in women of advanced reproductive age: a systematic review and meta-analysis of randomized controlled trials.
Conforti A; Esteves SC; Humaidan P; Longobardi S; D'Hooghe T; Orvieto R; Vaiarelli A; Cimadomo D; Rienzi L; Ubaldi FM; Zullo F; Alviggi C
Reprod Biol Endocrinol; 2021 Jun; 19(1):91. PubMed ID: 34154604
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of human menopausal gonadotropin versus recombinant follicle-stimulating hormone for controlled ovarian hyperstimulation in assisted reproductive cycles: a meta-analysis.
van Wely M; Westergaard LG; Bossuyt PM; van der Veen F
Fertil Steril; 2003 Nov; 80(5):1086-93. PubMed ID: 14607553
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of follitropin alfa/lutropin alfa in ART: a randomized controlled trial in poor ovarian responders.
Humaidan P; Chin W; Rogoff D; D'Hooghe T; Longobardi S; Hubbard J; Schertz J;
Hum Reprod; 2017 Mar; 32(3):544-555. PubMed ID: 28137754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
